Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05988073 · ClinicalTrials.gov registry record
A Prospective Longitudinal Study in Adults With Multifocal Motor Neuropathy
A clinical trial of Multifocal Motor Neuropathy, sponsored by argenx.
- Active
- Registry status
- 413
- Enrollment target
- 20
- Study locations
NCT05988073 is a study of Multifocal Motor Neuropathy that is active but no longer recruiting, run by argenx. The registered enrollment target is 413 participants. The trial reports 20 study locations across 13 states.
The verdict
NCT05988073, a study of Multifocal Motor Neuropathy, is active but no longer recruiting, sponsored by argenx.
- ACTIVE NOT RECRUITING
- Registry status
- 413 participants
- Enrollment target
- 20
- Study locations
Study Summary
This prospective longitudinal study will follow participants with Multifocal Motor Neuropathy over time and collect data on their clinical outcomes, quality of life, and use of health care resources. Participants will follow their regular visit schedule with their treating physician, except for an optional second visit occurring 7 to 14 days after the start of the study to collect biomarker data. No IMP will be administered.
Conditions Studied
Study Locations (20)
California
- UCI Health - ALS and Neuromuscular Center - Orange
- Stanford Medicine Health Care - Stanford Neuroscience Health Center - Palo Alto
- The Neurology Group - Pomona
- Eisenhower Health - Rancho Mirage Medical Center - Rancho Mirage
- UC Davis Health - Lawrence J. Ellison Ambulatory Care Center - Sacramento
- UCSF Health - UCSF Medical Center - San Francisco
Arizona
- Neuromuscular Clinical and Research Center - Phoenix
- HonorHealth Neurology - Bob Bove Neuroscience Institute - Scottsdale
Florida
- Medsol Clinical Research Center Inc - Port Charlotte
- D&H National Research Centers - Tamarac Research Center - Tamarac
Colorado
- University of Colorado - Anschutz Medical Campus - Aurora
Connecticut
- YaleNewHavenHealth - Yale New Haven Hospital - New Haven
Illinois
- Hospital Sisters Health System (HSHS) - St Elizabeth's Hospital - O'Fallon
Kansas
- The University of Kansas Health System - Landon Center on Aging - Kansas City
Maryland
- MedStar Georgetown University Hospital - Chevy Chase
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 413 participants |
| Start Date | 2023-11-29 |
| Est. Completion | 2028-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05988073
The ClinicalTrials.gov registry entry for NCT05988073 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 413 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is argenx, which has 49 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Multifocal Motor Neuropathy appearing as the primary indexed condition, and to 0 interventions.
NCT05988073 reports 20 study locations spanning 13 distinct geographic areas - top geographies include California, Arizona, Florida.
Frequently Asked Questions
What is clinical trial NCT05988073 about?
NCT05988073 is a clinical study titled "A Prospective Longitudinal Study in Adults With Multifocal Motor Neuropathy". This prospective longitudinal study will follow participants with Multifocal Motor Neuropathy over time and collect data on their clinical outcomes, quality of life, and use of health care resources. Participants will follow their regular visit schedule with their treating physician, except for an o...
What is the current status of trial NCT05988073?
This trial is currently active not recruiting. The enrollment target is 413 participants. The study started on 2023-11-29. Estimated completion is 2028-12-31.
What conditions does trial NCT05988073 study?
This clinical trial studies the following conditions: Multifocal Motor Neuropathy.
Who is sponsoring clinical trial NCT05988073?
This trial is sponsored by argenx, which has 49 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05988073 being conducted?
This trial has 20 study locations across Arizona, California, Colorado, Connecticut, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multifocal Motor Neuropathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.